
ISMMS: A premier private medical school in NYC, integral to the Mount Sinai Health System.
The Icahn School of Medicine at Mount Sinai (ISMMS), established in New York City, is a premier private medical school that serves as the academic teaching arm of the Mount Sinai Health System. The institution's core mission is to advance medical education, research, and clinical care. ISMMS offers a range of programs including MD, PhD, and dual-degree options, focusing on innovative biomedical research and patient-centered healthcare. The school is dedicated to training the next generation of medical professionals and researchers, with a strong emphasis on addressing complex health issues and improving patient outcomes.
Notable affiliated individuals include renowned researchers and clinicians who contribute significantly to various fields of medicine. The school has received substantial support from prominent investors and philanthropists, such as Carl Icahn, after whom the institution is named. ISMMS has achieved significant milestones in medical research, particularly in genomics, cancer, and neuroscience. Its impact is evident through its contributions to groundbreaking medical discoveries and its role in shaping modern healthcare practices.
Companies similar to Icahn School of Medicine at Mount Sinai include NYU Grossman School of Medicine, Yale School of Medicine, Harvard Medical School and Boston University School of Medicine.
Icahn School of Medicine at Mount Sinai was founded in 1963.
Icahn School of Medicine at Mount Sinai's headquarters is located in New York City, NY, US.
Icahn School of Medicine at Mount Sinai's most recent funding round was for $4M (USD) in January 2024.
As of Jan 25, 2024, Icahn School of Medicine at Mount Sinai has raised a total of $11.3M (USD).
Icahn School of Medicine at Mount Sinai has 3,770 employees as of Feb 4, 2024.

Harvard Medical School
hms.harvard.edu